|
Aflibercept Clinical Trials
2 actively recruiting trials across 2 locations
▲ +1 trial since September 2026
Also known as: Eylea
Pipeline
Phase 3: 2
Top Sponsors
- Merck Sharp & Dohme LLC2
Indications
- Macular Edema2
- Diabetic Retinopathy2
- Diabetes2
Gilbert, Arizona1 trial
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Associated Retina Consultants, Ltd ( Site 0084)
Phase 3
Waterford, Connecticut1 trial
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Retina Group of New England ( Site 0101)
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.